Ovarian Cancer | Cases from the Community: Investigators Discuss the Role of PARP Inhibition in the Care of Actual Patients with Ovarian Cancer (Faculty Presentations)

published 1 month ago by Dr Neil Love

Featuring slide presentations and related discussion from Drs Susana Banerjee, Richard T Penson and Shannon Westin, including the following topics: Genetic Testing in Ovarian Cancer: Integration of PARP Inhibitor Maintenance into the Management of Newly Diagnosed BRCA Mutation-Positive Ovarian Cancer — Susana Banerjee, MBBS, MA, PhD (0:00) Clinical Utility of PARP Inhibitor Maintenance in Patients with BRCA Wild-Type Advanced Ovarian Cancer — Richard T Penson, MD, MRCP (42:11) PARP Inhibitors in Combination with Immunotherapeutic and Chemotherapeutic Agents in the Management of Advanced Ovarian Cancer — Shannon N Westin, MD, MPH (1:15:14) CME information and select publications

more episodes from Research To Practice | Oncology Videos